![Anne Phelan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anne Phelan
Directeur Technique/Scientifique/R&D chez
BENEVOLENTAI S.A.
Profil
Anne Phelan is currently the Director at BenevolentAI Cambridge Ltd., the Chief Scientific Officer at BenevolentAI Ltd., and the Chief Scientific Officer at BenevolentAI SA. Previously, she worked as the Executive Vice President & Head-Research at MISSION Therapeutics Ltd. in 2018 and as the Chief Operating Officer & Head-Pharmacology at Pfizer Inc. from 2014 to 2015.
Dr. Phelan obtained her undergraduate and doctorate degrees from the University of Liverpool.
Postes actifs de Anne Phelan
| Sociétés | Poste | Début |
|---|---|---|
| BENEVOLENTAI S.A. | Directeur Technique/Scientifique/R&D | 01/11/2019 |
BenevolentAI Cambridge Ltd.
 BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Directeur/Membre du Conseil | 03/01/2019 |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Directeur Technique/Scientifique/R&D | 01/09/2019 |
Anciens postes connus de Anne Phelan
| Sociétés | Poste | Fin |
|---|---|---|
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Directeur Technique/Scientifique/R&D | 01/11/2018 |
| PFIZER INC. | Corporate Officer/Principal | 01/10/2015 |
Formation de Anne Phelan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
BenevolentAI Cambridge Ltd.
BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services to pharmaceutical companies in the areas of Parkinsons disease and other neurodegenerative disorders | Commercial Services |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
BenevolentAI Ltd.
BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Technology Services |
University of Liverpool
 University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
